Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

One Health approach strengthened

New UK strategy to tackle antimicrobial resistance

A UK Five Year Antimicrobial Resistance Strategy has been published, calling for a One Health approach in both human and animal medicine.

It follows a report, which dates back to March, put together by the UK's chief medical officer to highlight the scale of threat from antimicrobial resistance.

Taking effect from 2013 to 2018, the strategy has been jointly published by the Department for Environment, Food and Rural Affairs (Defra), the Department of Health, Scottish Government, Welsh Government and the Northern Ireland Executive.

It outlines the following seven key areas for action over the next five years:

1. Improving infection prevention and control practices
2. Optimising prescribing practice
3. Improving education, training and public engagement
4. Developing new drugs, treatments and diagnostics
5. Better access to and use of surveillance
6. Better identification and prioritisation or antimicrobial resistance research needs
7. Strengthened international collaboration

The strategy also details specific duties under each sector and acknowledges action already taken within the veterinary profession, such as the Royal College of Veterinary Surgeons' guidelines and posters of responsible antimicrobial use.

It has been made clear in the report that scientific evidence suggests antibiotic use in humans, rather that animals, is the primary cause of clinical antimicrobial resistance issues in human medicine.

However, its use in animals is also a contributory factor that must be addressed.

Peter Jones, president of the British Veterinary Association (BVA), said: "Antimicrobial resistance is indeed one of the most significant threats to animal and human health and we fully support the aims of the UK strategy.

"We fully recognise the need to tackle resistance in animals… the One Health approach of medical and veterinary professionals working together will be crucial to the success of the strategy."

Related News
Ants offer lead on new antibiotics
Step forward in fighting superbugs

 

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.